More about

Hepatocellular Carcinoma

News
February 19, 2024
3 min watch
Save

VIDEO: GIs will need to become ‘better at hepatology’ ahead of looming workforce shortage

In a Healio video exclusive, Edward V. Loftus Jr., MD, urged gastroenterologists to familiarize themselves with a “four-pronged approach to liver disease” ahead of the critical shortage of U.S. hepatologists expected by 2033.

News
February 19, 2024
3 min read
Save

‘Not simply a hand-off’: GIs, hepatologists have critical role in HCC care after diagnosis

The role of gastroenterologists and hepatologists in the management of patients at risk for or with hepatocellular carcinoma is multifold.

News
February 05, 2024
1 min read
Save

Portal vein thrombosis rates higher after TACE, but ‘negligible’ effect on clinical course

Incidence of new portal vein thrombosis was higher after transarterial chemoembolization for hepatocellular carcinoma compared with microwave or radiofrequency ablation, although researchers reported no clinically significant sequalae.

News
January 18, 2024
4 min read
Save

Potential of sound waves to destroy liver tumors generates ‘good deal of excitement’

A sound wave technique pioneered at University of Michigan has exhibited preliminary efficacy as a treatment for liver cancer.

News
January 08, 2024
1 min watch
Save

VIDEO: Race, biomarkers among risk factors for HCC in spontaneously cleared HCV

BOSTON — According to an abstract at The Liver Meeting, patients of Hispanic ethnicity who had elevated liver enzymes at baseline remained at increased risk for hepatocellular carcinoma, despite spontaneously clearing hepatitis C virus.

News
December 20, 2023
2 min read
Save

Universal HCV screening, linkage to care 'effective’ cancer prevention strategy

BOSTON — Implementation of universal hepatitis C virus screening at cancer centers and corresponding care may positively affect HCV elimination targets and improve public health outcomes, according to a presentation at The Liver Meeting.

News
December 19, 2023
4 min watch
Save

VIDEO: Treatment for hepatitis C virus infection still low among patients with HCC

BOSTON — In this video, Norah Terrault, MD, MPH, FAASLD, discusses data from The Liver Meeting on treatment of hepatitis C virus infection among individuals with hepatocellular carcinoma.

News
December 15, 2023
2 min read
Save

Agent Orange exposure not among risk factors linked to liver cancer in Vietnam veterans

Researchers found no association between Agent Orange exposure and hepatocellular carcinoma among Vietnam veterans, according to study results published in JAMA Network Open.

News
December 13, 2023
2 min read
Save

Liver transplant rates for HCC decline across all races after 2015 MELD policy change

Asian patients with hepatocellular carcinoma had the lowest waitlist dropout rates and highest 5-year survival after liver transplantation before and after the policy change, while Black or African American patients had the worst outcomes.

News
December 07, 2023
2 min read
Save

Tenofovir disoproxil linked to better long-term outcomes vs. entecavir in HBV-related HCC

Tenofovir disoproxil improved long-term overall and recurrence-free survival rates compared with entecavir among patients with hepatitis B virus-related hepatocellular carcinoma who underwent liver resection.

View more